EQT Life Sciences's book
36 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Tubulis | Drug Discovery | $5.8B | — | — | |
| DNA Script | Biotechnology | $659.7M | — | — | |
| VarmX | — | $505.0M | — | — | |
| Electra Therapeutics | Drug Discovery | $479.0M | — | — | |
| AgomAb | Drug Discovery | $415.6M | — | — | |
| Binx | — | $333.9M | — | — | |
| Artios | Drug Discovery | $260.3M | — | — | |
| Noema Pharma | — | $228.8M | — | — | |
| Kinaset Therapeutics | Drug Discovery | $186.0M | — | — | |
| AviadoBio | — | $181.8M | — | — | |
| + 26 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 36 recorded positions
- ·Watchlist + alerts for EQT Life Sciences's activity
Create free account
No card required